Nwk Group, Inc. Pfizer Inc Transaction History

Nwk Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $89,774 - $101,700	-2,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $9,747 - $11,435	-307 Reduced 10.94%	2,500 $92,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $9,246 - $11,217	307 Added 12.28%	2,807 $92,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $15,028 - $21,472	-556 Reduced 18.19%	2,500 $82,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $100,603 - $114,172	3,056 New	3,056 $120,000

3,375

3.69B

106M

123M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.